Login / Signup

[Drug monitoring of the antibacterial drug Vancomycin in patients with purulent-inflammatory diseases of the maxillofacial region].

N M KhelminskayaVictor S KravetsA V PosadskayaD A EreminA V MartirosovSh M Bugaev
Published in: Stomatologiia (2023)
To achieve the therapeutic effect of phlegmon treatment, it is necessary to select an individual dose of the drug for each patient.
Keyphrases
  • case report
  • adverse drug
  • oxidative stress
  • methicillin resistant staphylococcus aureus
  • drug induced
  • emergency department
  • staphylococcus aureus
  • silver nanoparticles
  • replacement therapy